138 related articles for article (PubMed ID: 37401466)
1. Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia.
Bogani G; Sopracordevole F; Ciavattini A; Vizza E; Vercellini P; Giannini A; Ghezzi F; Scambia G; Raspagliesi F; Di Donato V;
Eur J Cancer Prev; 2023 Nov; 32(6):525-532. PubMed ID: 37401466
[TBL] [Abstract][Full Text] [Related]
2. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women.
Bogani G; Pinelli C; Chiappa V; Martinelli F; Lopez S; Ditto A; Raspagliesi F
J Gynecol Oncol; 2020 Sep; 31(5):e60. PubMed ID: 32808492
[TBL] [Abstract][Full Text] [Related]
3. Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study.
Schuurman TN; Schaafsma M; To KH; Verhoef VMJ; Sikorska K; Siebers AG; Wenzel HHB; Bleeker MCG; Roes EM; Zweemer RP; de Vos van Steenwijk PJ; Yigit R; Beltman JJ; Zusterzeel PLM; Lok CAR; Bekkers RLM; Mom CH; van Trommel NE
Lancet Oncol; 2023 Dec; 24(12):1349-1358. PubMed ID: 37952541
[TBL] [Abstract][Full Text] [Related]
4. Nomogram-based prediction of cervical dysplasia persistence/recurrence.
Bogani G; Tagliabue E; Ferla S; Martinelli F; Ditto A; Chiappa V; Leone Roberti Maggiore U; Taverna F; Lombardo C; Lorusso D; Raspagliesi F
Eur J Cancer Prev; 2019 Sep; 28(5):435-440. PubMed ID: 30489353
[TBL] [Abstract][Full Text] [Related]
5. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study.
Bogani G; DI Donato V; Sopracordevole F; Ciavattini A; Ghelardi A; Lopez S; Simoncini T; Plotti F; Casarin J; Serati M; Pinelli C; Valenti G; Bergamini A; Gardella B; Dell'acqua A; Monti E; Vercellini P; Fischetti M; D'Ippolito G; Aguzzoli L; Mandato VD; Carunchio P; Carlinfante G; Giannella L; Scaffa C; Falcone F; Borghi C; Ditto A; Malzoni M; Giannini A; Salerno MG; Liberale V; Contino B; Donfrancesco C; Desiato M; Perrone AM; Dondi G; De Iaco P; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Ferrero S; Sarpietro G; Matarazzo MG; Cianci A; Bosio S; Ruisi S; Guerrisi R; Brusadelli C; Mosca L; Tinelli R; DE Vincenzo R; Zannoni GF; Ferrandina G; Petrillo M; Dessole S; Angioli R; Greggi S; Spinillo A; Ghezzi F; Colacurci N; Muzii L; Benedetti Panici P; Scambia G; Raspagliesi F
Gynecol Oncol; 2020 Dec; 159(3):636-641. PubMed ID: 32893030
[TBL] [Abstract][Full Text] [Related]
6. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
[TBL] [Abstract][Full Text] [Related]
7. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with the persistence of human papillomavirus after cervical excision in patients with high-grade squamous intra-epithelial neoplasia.
Zang L; Huang J; Zhu J; Hu Y
Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():175-181. PubMed ID: 34689015
[TBL] [Abstract][Full Text] [Related]
9. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approach.
Bogani G; Ditto A; Martinelli F; Signorelli M; Chiappa V; Leone Roberti Maggiore U; Taverna F; Lombardo C; Borghi C; Scaffa C; Lorusso D; Raspagliesi F
Eur J Cancer Prev; 2019 Mar; 28(2):81-86. PubMed ID: 29360648
[TBL] [Abstract][Full Text] [Related]
11. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
12. [The role of HPV genotyping testing in follow-up of high grade squamous intraepithelial lesion after treatment].
Li N; Zuo J; Huang Y; An J; Yao H; Li X; Zhang R; Li B; Zhang X; Guo H; Wu L
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):258-62. PubMed ID: 26080936
[TBL] [Abstract][Full Text] [Related]
13. Correlation of the HPV 16 Genotype Persistence in Women Undergoing LEEP for CIN3 with the Risk of CIN2+ Relapses in the First 18 Months of Follow-Up: A Multicenter Retrospective Study.
Bruno MT; Valenti G; Ruggeri Z; Incognito GG; Coretti P; Montana GD; Panella MM; Mereu L
Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472983
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus genotype testing combined with cytology as a 'test of cure' post treatment: the importance of a persistent viral infection.
Jones J; Saleem A; Rai N; Shylasree TS; Ashman S; Gregory K; Powell N; Tristram A; Fiander A; Hibbitts S
J Clin Virol; 2011 Oct; 52(2):88-92. PubMed ID: 21831706
[TBL] [Abstract][Full Text] [Related]
16. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis.
Koshiol J; Lindsay L; Pimenta JM; Poole C; Jenkins D; Smith JS
Am J Epidemiol; 2008 Jul; 168(2):123-37. PubMed ID: 18483125
[TBL] [Abstract][Full Text] [Related]
17. FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.
Vink FJ; Meijer CJLM; Hesselink AT; Floore AN; Lissenberg-Witte BI; Bonde JH; Pedersen H; Cuschieri K; Bhatia R; Poljak M; Oštrbenk Valenčak A; Hillemanns P; Quint WGV; Del Pino M; Kenter GG; Steenbergen RDM; Heideman DAM; Bleeker MCG
Clin Infect Dis; 2023 Feb; 76(3):e827-e834. PubMed ID: 35686306
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational study in China.
Chen M; Li C; Cui Q; Zhou C; Chen P; Yao S
Eur J Obstet Gynecol Reprod Biol; 2023 Jul; 286():10-15. PubMed ID: 37159990
[TBL] [Abstract][Full Text] [Related]
19. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
20. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
